Studi Osservazionali 2022
| Title | Liver Investigation: Testing Marker Utility in Steatohepatitis (LITMUS): Assessment & Validation of Imaging Modality Performance Across the NAFLD Spectrum in a Prospectively Recruited Cohort |
| NCT Number | NCT05479721 IRAS ID 250344 18/LO/1953 (Other Identifier: NHS Health Research Authority) |
| Conditions | NAFLD NASH NASH - Nonalcoholic Steatohepatitis Fibrosis, Liver Steatosis of Liver |
| Interventions | |
| Sponsor/Collaborators | University of Oxford |
| Gender | All |
| Age | 18 Years to 100 Years (Adult, Older Adult) |
| Phases | |
| Enrollment | 450 participants |
| Study Type | Observational |
| Study Designs | Cohort |
| Start Date | 04/09/2019 |
| Completion Date | 31/10/2022 |
| Locations | A.O.U. Policlinico P. Giaccone di Palermo, U.O.C. Gastroenterologia, prof. Salvatore Petta |
| URL | https://www.clinicaltrials.gov/ct2/show/NCT05479721 |
| Title | Retrospective Observational Study on Dalbavancin Real-life Utilization in Diabetic Patients Suffering From Infections - DALBADIA Study |
| NCT Number | NCT04959799
146(Z)PO20094 |
| Conditions | Intervention/treatment Diabetes Infection |
| Interventions | Drug: Dalbavancin |
| Sponsor/Collaborators | Aziende Chimiche Riunite Angelini Francesco S.p.A |
| Gender | All |
| Age | 18 Years and older (Adult, Older Adult) |
| Phases | |
| Enrollment | 98 |
| Study Type | Observational |
| Study Designs | Cohort |
| Start Date | 02/01/2022 |
| Completion Date | 31/05/2022 |
| Locations | A.O.U. Policlinico P. Giaccone di Palermo, U.O.C. di Malattie Infettive, Prof. Antonio Cascio |
| URL | https://www.clinicaltrials.gov/ct2/show/NCT04959799 |
| Title | A Multicenter, Non-Interventional Study to Evaluate Physical Activity, Bleeding Incidence and Health Related Quality of Life, in Patients With Haemophilia A Without Inhibitors Receiving Standard of Care Treatment |
| NCT Number | NCT04165135 |
| Conditions | Severe Hereditary Factor VIII Deficiency Disease Without Inhibitor Moderate Hereditary Factor VIII Deficiency Disease Without Inhibitor Haemophilia A |
| Interventions | Drug: Standard of Care for Haemophilia A |
| Sponsor/Collaborators | Hoffmann-La Roche |
| Gender | All |
| Age | 12 Years to 50 Years (Child, Adult) |
| Phases | |
| Enrollment | 107 |
| Study Type | Observational |
| Study Designs | Cohort |
| Start Date | 24/02/2020 |
| Completion Date | 28/04/2022 |
| Locations | A.O.U. Policlinico P. Giaccone di Palermo, U.O.C. di Ematologia, Prof. Sergio Siragusa |
| URL | https://www.clinicaltrials.gov/ct2/show/NCT04165135 |
Studi Osservazionali – Anno 2022
|
Data |
Titolo |
Docente/i del Dipartimento |
|
01/01/2022 |
Pneumococcal carriage in Sicily in the pre-COVID-19 era: a retrospective study over a 5-year period |
Fabio Tramuto |
|
01/01/2022 |
Progetto in collaborazione con la European Medicine Agency e l’Università degli Studi di Verona “Covid19-Vaccine-Monitor” |
Claudio Costantino (Francesco Vitale – Ilaria Morreale) |
|
01/01/2022 - 31/12/2022 |
Studio dal titolo: LIPIGEN (Lipid TransPort Disorders italian Genetic Network) |
Proff. Maurizio Averna e Angelo Baldassare Cefalù |
|
01/01/2022 - 31/12/2022 |
Studio dal titolo: HOFH, THE INTERNATIONAL CLINICAL COLLABORATORS (HICC) A GLOBAL HOFH DATA-SHARING PLATFORM |
Proff. Maurizio Averna e Angelo Baldassare Cefalù |
|
01/01/2022 - 31/12/2022 |
Registro dal titolo: LOWER: Lomitapide Observational Worldwide Evaluation Registry |
Proff. Maurizio Averna e Angelo Baldassare Cefalù |
|
14/04/2022 |
“Observational study on GUselkumab: effectiveness and impact on quaLity of LIfe in naïVE or bio experienced patients with Regional (facial and genital)” – Studio GULLIVER Prot. CNTO1959PSO4013 |
Prof.ssa Maria Rita Bongiorno e Prof. Giuseppe Pistone |
|
14/04/2022 |
SERENA Study: Long-term observational, prospective study to collect in a real life setting data on the retention, effectiveness, safety, treatment pattern, quality of life, and efficiency of secukinumab in adult patients with moderate to severe plaque psoriasis, psoriatic arthritis or ankylosing spondylitis – Prot. CAIN457A3403 |
Prof.ssa Maria Rita Bongiorno e Prof. Giuseppe Pistone |
|
30/06/2022 |
Confronto di efficacia tra dapagliflozin ed farmaci ipoglicemizzanti (non insulina, non altri SGLT2 inibitori) su endpoints renali nel diabete tipo 2. Studio real-world multicentrico italiano – DARWIN-Renal |
Prof. Roberto Citarrella |
|
30/06/2022 |
Progetto: LIFE FOOD DIET : CERTIFICAZIONE DI SISTEMA |
Prof. Alberto Firenze |
|
30/06/2022 |
Progetto: Stress lavoro correlato |
Prof. Alberto Firenze |
|
30/06/2022 |
Progetto: APP. i VIAGGIO |
Prof. Alberto Firenze |
|
30/06/2022 |
Progetto: INDOOR |
Prof. Alberto Firenze |
|
30/06/2022 |
Progetto: Safety Walk Round |
Prof. Alberto Firenze |
|
30/06/2022 |
Progetto: Educazione alla vita |
Prof. Alberto Firenze |
|
30/06/2022 |
Progetto: Hospital Chef |
Prof. Alberto Firenze |
|
30/06/2022 |
Progetto: Serve una mano? |
Prof. Alberto Firenze |
|
30/06/2022 |
Progetto: Quater sicurezza del paziente: sviluppo e implementazione della rete dei risk manager nella regione Sicilia |
Prof. Alberto Firenze |
|
30/06/2022 |
Progetto: Audit civico |
Prof. Alberto Firenze |
|
30/06/2022 |
Registro Nazionale Malattie Rare |
Prof.ssa Giuliana Guggino |
|
30/06/2022 |
Registro GIRRCS: valutazione efficacia switch secukinumab – ixekizumab |
Prof.ssa Giuliana Guggino |
|
30/06/2022 |
sjogren syndrome… |
Prof.ssa Giuliana Guggino |
|
30/06/2022 |
Registro GIRRCS SAK INHIBITORS |
Prof.ssa Giuliana Guggino |
|
30/06/2022 |
Psoriatie arthrims observational study of persistence of treatment (pro-spirit study) |
Prof.ssa Giuliana Guggino |
|
30/06/2022 |
Studio osservazionale prospettivo ….. |
Prof.ssa Giuliana Guggino |
|
30/06/2022 |
Studio osservazionale non interventistico… |
Prof.ssa Giuliana Guggino |
|
30/06/2022 |
Tasso di resistenza in terapia di anakinra ….. |
Prof.ssa Giuliana Guggino |
|
30/06/2022 |
START:….. |
Prof.ssa Giuliana Guggino |
|
30/06/2022 |
Registro italiano di Fibromialgia |
Prof.ssa Giuliana Guggino |
